Nessan Bermingham
Overview
Nessan Bermingham received an average of $5M in total compensation, including $453K in salary, at Intellia Therapeutics from 2015 to 2017.
Source: SEC filings on April 17, 2018 and April 18, 2017.
Related executives
We found eight more executives who work or worked at Intellia Therapeutics.
James Basta
Intellia Therapeutics
General Counsel
John Leonard
Intellia Therapeutics
Chief Executive Officer
Laura Sepp-Lorenzino
Intellia Therapeutics
Chief Scientific Officer
David Lebwohl
Intellia Therapeutics
Chief Medical Officer
Glenn Goddard
Intellia Therapeutics
Chief Financial Officer
Andrew Schiermeier
Intellia Therapeutics
Chief Operating Officer
José Rivera
Intellia Therapeutics
General Counsel
Graeme Bell
Intellia Therapeutics